Back to search
FDAFDA · Food and drugs·Recall number Z-1734-2025

GALT Guidewire REF SGW-051-07 Guidewires are intended for use in percutaneous procedures, to introduce and position catheters and other interventional devices within the Coronary and peripheral vasculature.

Published May 14, 2025 · Recall initiated: March 27, 2025

Summary

FDA records medical device Class II recall Z-1734-2025, published May 14, 2025 and initiated March 27, 2025. Recalling firm: Galt Medical Corporation; Status: Ongoing; Reported quantity: 100 guidewires; Lot: Catalog Number: SGW-051-07 UDI-DI code: 0084126810132 Lot Number: 25050797. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to a potential open seal in the sterile barrier packaging.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Galt Medical Corporation
Distributor
Worldwide - U.S. Nationwide distribution in the states of AL, FL, GA, IL, MA, OH, PA, and UT. The countries of Canada, Ireland, Israel, Korea, Qatar, and United Kingdom.
Lot
Catalog Number: SGW-051-07 UDI-DI code: 0084126810132 Lot Number: 25050797
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was GALT Guidewire REF SGW-051-07 Guidewires are intended for use in percutaneous procedures, to introduce and position catheters and other interventional devices within the Coronary and peripheral vasculature. recalled?

Yes. FDA published recall Z-1734-2025 on May 14, 2025. Reported hazard: Due to a potential open seal in the sterile barrier packaging.

What should I do if I have this product?

Voluntary: Firm initiated · Letter